- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02198066
A Comparison of Post-Sternotomy Dressings
July 21, 2014 updated by: Carilion Clinic
The purpose of this study was to determine which of three types of dressings, a dry sterile dressing, a metallic silver dressing or an ionic silver dressing provided better patient outcomes for the post-sternotomy cardiac surgery patient population.
In this prospective, randomized controlled trial, the hypothesis was that subjects who received either of the silver impregnated dressings would have better outcomes (better wound healing, less discomfort, and less incidence of infection).
Investigators also evaluated dressing factors such as adherence, time for application and ease of use.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
No other information included.
Study Type
Interventional
Enrollment (Actual)
351
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Virginia
-
Roanoke, Virginia, United States, 24014
- Carilion Roanoke Memorial Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Adult (at least 21 years of age) inpatients awaiting cardiac surgery or outpatients seen in the pre-surgical testing area prior to admission for surgery
- Having surgery at the study setting
- English-speaking
- Able to understand and give consent
- Had the approval of their cardiothoracic surgeon to participate
- Had no known sensitivity to silver
- Had no known sensitivity to alginates
Exclusion Criteria:
- Known sensitivity to silver
- Known sensitivity to alginates
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Dry Sterile Dressing
Subjects in this study arm received a dry sterile dressing (Primapore®, Smith & Nephew), a one-piece, peel-and-stick, non-transparent dressing.
This dressing is the standard of care at the study facility for this population and was left in place for either 24 to 48 hours.
|
Described in Arm Description.
Other Names:
|
Active Comparator: Metallic Silver Dressing
Subjects in this arm received a metallic silver dressing (Acticoat Post-Op®, Smith & Nephew), a one-piece, peel-and-stick and non-transparent dressing.
This dressing is an absorbent postoperative dressing consisting of a nanocrystalline silver-coated polyurethane layer, a white polyurethane foam and an adhesive coated waterproof polyurethane film layer.
Acticoat Post-Op may be left in place over a wound for up to 7 days.
The manufacturers note that the product should not be used in patients with known silver allergies and that it may cause transient discoloration of the skin.
|
Described in Arm Description.
Other Names:
|
Active Comparator: Ionic Silver Dressing
Subjects in this arm received an ionic silver dressing (Dermanet Ag®, DeRoyal), a semi-transparent dressing that includes silver, alginate, and maltodextrin.
The dressing was cut to fit the incision and then covered with a transparent dressing (Transseal®, DeRoyal).
This dressing should not be used on patients with known sensitivity to alginates (a seaweed based component).
|
Described in Arm Description.
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Wound Healing
Time Frame: 5 days postoperatively or day of discharge, whichever came first
|
The primary outcome measure in this study was wound healing, defined as the degree of wound approximation, skin integrity, exudate, and presence/absence of necrotic tissue, assessed at postoperative day 5 or day of discharge.
Wound approximation was assessed as total, partial (less than 2 centimeters of superficial separation), moderate (greater than 2 centimeters of superficial separation), or dehisced (complete separation of layers).
Skin integrity was evaluated as normal (pink, no redness), inflamed, (heat, redness, swelling), or macerated within a 2.5 centimeter border of the incision.
Exudate quality was assessed as purulent, blood, serosanguinous, or serous.
Presence or absence of necrotic tissue was noted.
|
5 days postoperatively or day of discharge, whichever came first
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Patient Comfort
Time Frame: 5 days postoperatively or day of hospital discharge, whichever came first
|
The secondary outcome measure in this study was patient comfort with the dressing in place and upon removal.
Comfort was measured using a 0-10 scale, with 0 signifying no pain and 10 signifying maximum pain.
|
5 days postoperatively or day of hospital discharge, whichever came first
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dressing Factors
Time Frame: 5 days postoperatively or at day of discharge, whichever came first
|
Dressing factors of ease of application, removal, and incision assessment were measured on a 5-point Likert-type scale (1=very easy, 2=moderately easy, 3=neither easy nor hard, 4=moderately hard, and 5=very hard).
Dressing integrity was assessed as suture line exposed, poorly sealed (imperfect covering of the suture line with the potential for organism entry), or well-sealed.
|
5 days postoperatively or at day of discharge, whichever came first
|
Sternal Wound Infection
Time Frame: 30 days postoperatively
|
Investigators evaluated sternal wound infection presence and type (superficial or deep) using Centers for Disease Control/National Healthcare Safety Network surveillance definitions.
|
30 days postoperatively
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Cathy D. Jennings, DNP, Carilion Clinic
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
July 1, 2010
Primary Completion (Actual)
August 1, 2012
Study Completion (Actual)
August 1, 2012
Study Registration Dates
First Submitted
March 27, 2014
First Submitted That Met QC Criteria
July 21, 2014
First Posted (Estimate)
July 23, 2014
Study Record Updates
Last Update Posted (Estimate)
July 23, 2014
Last Update Submitted That Met QC Criteria
July 21, 2014
Last Verified
March 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CC-2014-1
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Impaired Wound Healing
-
University of Witten/HerdeckeKCI Europe Holding B.V.CompletedImpaired Wound Healing | Wound Healing Disorder | Abdominal Wound Healing Disorder | Abdominal Wound Healing Impairment | Acute Postsurgical Subcutaneous WoundBelgium, Germany
-
Massachusetts General HospitalMomelan TechnologiesTerminatedImpaired Wound HealingUnited States
-
HealthpointCompleted
-
Universidade Estadual Paulista Júlio de Mesquita...RecruitingWound Healing | Palate; WoundBrazil
-
Stratpharma AGUniversity Hospital, GenevaCompleted
-
Johnson & Johnson Consumer Inc. (J&JCI)CompletedWound HealingUnited States
-
University Hospital, GhentCompleted
-
Dow University of Health SciencesUnknown
-
Peking University Third HospitalCompleted
Clinical Trials on Dry Sterile Dressing
-
Mayo Clinic3MCompletedSurgical Wound InfectionUnited States
-
Medical University of South Carolina3MRecruitingSarcoma | Cancer | Infectious DiseaseUnited States
-
Corporacion Parc TauliKerbi Alejandro Guevara-Noriega, Sabadell, Parc Tauli, Spain; Elena Gonzalez... and other collaboratorsRecruiting
-
Peking University Third HospitalNot yet recruiting
-
University of Lausanne HospitalsRecruitingAmputation | Arthroplasty Complications | Prosthesis-Related InfectionsSwitzerland
-
Yuksek Ihtisas HospitalCompletedNewborn | Peripheral Venous CatheterizationTurkey
-
Georgetown UniversityUnknownEvaluating the Outcomes for Incisional Application of Negative Pressure for Nontraumatic AmputationsAmputation | Surgical Wound | Wound HealUnited States
-
Andrew GlennieUnknownSurgical Site Infection
-
McMaster UniversityRecruitingVentral HerniaCanada